Biomarkers in Down syndrome can help us understand Alzheimer's disease
- PMID: 32593327
- DOI: 10.1016/S0140-6736(20)30916-8
Biomarkers in Down syndrome can help us understand Alzheimer's disease
Comment on
-
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.Lancet. 2020 Jun 27;395(10242):1988-1997. doi: 10.1016/S0140-6736(20)30689-9. Lancet. 2020. PMID: 32593336 Free PMC article.
Similar articles
-
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.Lancet Neurol. 2018 Oct;17(10):860-869. doi: 10.1016/S1474-4422(18)30285-0. Epub 2018 Aug 29. Lancet Neurol. 2018. PMID: 30172624
-
Diagnostic biomarkers of Alzheimer's disease in Down syndrome.Lancet Neurol. 2018 Oct;17(10):831-832. doi: 10.1016/S1474-4422(18)30293-X. Epub 2018 Aug 29. Lancet Neurol. 2018. PMID: 30172623 No abstract available.
-
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.Biochem Biophys Res Commun. 1984 Aug 16;122(3):1131-5. doi: 10.1016/0006-291x(84)91209-9. Biochem Biophys Res Commun. 1984. PMID: 6236805
-
Cognitive decline and dementia in Down syndrome.Curr Opin Psychiatry. 2017 Mar;30(2):102-107. doi: 10.1097/YCO.0000000000000307. Curr Opin Psychiatry. 2017. PMID: 28009725 Review.
-
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5. Eur J Pharmacol. 2017. PMID: 28987272 Review.
Cited by
-
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Review.
-
Correlating MRI-based brain volumetry and cognitive assessment in people with Down syndrome.Brain Behav. 2023 Oct;13(10):e3186. doi: 10.1002/brb3.3186. Epub 2023 Jul 26. Brain Behav. 2023. PMID: 37496380 Free PMC article.
-
Cognitive outcome measures for tracking Alzheimer's disease in Down syndrome.Int Rev Res Dev Disabil. 2022;62:227-263. doi: 10.1016/bs.irrdd.2022.05.006. Epub 2022 Jul 21. Int Rev Res Dev Disabil. 2022. PMID: 37396708 Free PMC article.
-
Postmortem Neocortical 3H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer's Disease.Front Aging Neurosci. 2021 Aug 13;13:728739. doi: 10.3389/fnagi.2021.728739. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34489686 Free PMC article.
-
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study.J Clin Med. 2021 Apr 28;10(9):1907. doi: 10.3390/jcm10091907. J Clin Med. 2021. PMID: 33924960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
